Ray Sumita's most recent trade in Cue Biopharma Inc was a trade of 18,196 Common Stock done . Disclosure was reported to the exchange on Aug. 13, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cue Biopharma Inc | Sumita Ray | Chief Legal Compliance Officer, Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2026 | 18,196 | 127,374 (0%) | 0% | 0 | Common Stock | |
| Cue Biopharma Inc | Sumita Ray | Chief Legal Compliance Officer, Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2026 | 18,196 | 36,393 | - | - | Common Stock | |
| Cue Biopharma Inc | Sumita Ray | Chief Legal Compliance Officer, Corporate Secretary | Sale of securities on an exchange or to another person at price $ 30.35 per share. | 13 Aug 2026 | 6,442 | 118,549 (0%) | 0% | 30.4 | 195,515 | Common Stock |
| Cue Biopharma Inc | Sumita Ray | Chief Legal Compliance Officer, Corporate Secretary | Sale of securities on an exchange or to another person at price $ 29.37 per share. | 13 Aug 2026 | 2,383 | 124,991 (0%) | 0% | 29.4 | 69,989 | Common Stock |
| Cue Biopharma Inc | Sumita Ray | Chief Legal Compliance Officer, Corporate Secretary | Sale of securities on an exchange or to another person at price $ 31.25 per share. | 13 Aug 2026 | 4 | 118,545 (0%) | 0% | 31.3 | 125 | Common Stock |
| Cue Biopharma Inc | Sumita Ray | Chief Legal Compliance Officer, Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 54,589 | 54,589 | - | - | Common Stock | |
| Cue Biopharma Inc | Sumita Ray | Chief Legal Compliance Officer, Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 54,589 | 109,178 (0%) | 0% | 0 | Common Stock | |
| Biomea Fusion Inc | Sumita Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 196,299 | 196,299 | - | - | Stock Option (Right to Buy) | |
| Biomea Fusion Inc | Sumita Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 91,970 | 91,970 | - | - | Stock Option (Right to Buy) | |
| Biomea Fusion Inc | Sumita Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 51,025 | 51,025 | - | - | Stock Option (Right to Buy) | |
| Instil Bio Inc | Sumita Ray | Chief Legal and Admin Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2023 | 415,000 | 415,000 | - | - | Employee Stock Option (right to buy) | |
| Instil Bio Inc | Ray Sumita | Chief Legal and Admin Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2023 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Biomea Fusion Inc | Sumita Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 23,867 | 23,867 | - | - | Stock Option (Right to Buy) | |
| Biomea Fusion Inc | Sumita Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 21,461 | 21,461 | - | - | Stock Option (Right to Buy) |